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latelet transfusion in dengue fever: a randomized controlled
rial
.Z.K. Assir1,∗, U. Kamran1, S. Bashir2, H.I. Ahmed1, S.B. Anees1,
. Akram1
Allama IqbalMedical College/ JinnahHospital Lahore, Lahore, Punjab,
akistan
Allama Iqbal Medical College/ Jinnah Hospital Lahore, Lahore,
akistan
Background: Immune mediated destruction of platelets can
ossibly lead to poor response to platelet transfusion in dengue
ever.Weconducted this trial to study effects of platelet transfusion
n dengue-related thrombocytopenia.
Methods: A single center, randomized, non blind trial was con-
ucted at Jinnah Hospital Lahore between August and October
011. Adults of the age ≥14 years with dengue fever or dengue
emorrhagic fever and platelet counts <30,000/mm3 were eli-
ible.Patients were randomized to treatment and control group.
reatment group received single donor platelets. Responsiveness
o platelet transfusion was assessed by 1 hr post-transfusion
latelet increments (PPI) and corrected count increments (CCI).
atients with PPI ≥10,000/mm3 and/or CCI≥5,000/mm3 1 hr
ost-transfusion were considered responders. Primary outcome
easurewas platelet count increments at 24 and 72hrs. Secondary
utcome measure was duration of bleeding.
Results: Eighty seven (87) patientswere enrolled and43 (48.2%)
eceived platelet transfusion. Mean PPI and CCI at 1 hr post-
ransfusion in treatment group were 18,800/mm3 (range -7,000
o 77,000) and 7,000/mm3 (range -1,050 to 27,260) respectively.
2 (53.6%) patients in treatment groupwere non-responders.Mean
latelet incrementswere higher in treatment group as compared to
ontrol group at 24hrs (34,780/mm3 vs 4,280/mm3, p<0.001) and
2hrs (75,430/mm3 vs 32,840/mm3, p=0.001). At 24hrs, respon-
ers showed signiﬁcantly higher increments (mean 53,310/mm3)
han non-responders (mean 18,770/mm3) and controls (mean
,280/mm3) (p=0.004, p <0.001 respectively). Signiﬁcant dif-
erence was also found between non-responders and controls
p <0.001). Similarly, 72hrs post-transfusion platelet increments
ere signiﬁcantly higher in responders (mean 103,440/mm3)
s compared to non-responders (mean 51,430/mm3) and con-
rol group (mean 32,840/mm3) (p=0.001, p <0.001 respectively).
owever, no signiﬁcant differences were found between non-
esponders andcontrol group (p=0.104). Three severeanaphylactic
eactions including two deaths occurred in treatment group. Both
eathswere innon-responders.No signiﬁcantdifferencewas found
n duration of bleeding between treatment and control group.
Conclusion: Although half of the patients show signiﬁcant
mprovement in platelet count following platelet transfusion, no
eneﬁcial effect occurs on duration of bleeding. Platelet transfu-
ion in dengue fever is associated with high incidence of severe
omplications including death and should not be routinely done.
he risk of complications is higher in non-responders.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.878fectious Diseases 16S (2012) e158–e316
Type: Poster Presentation
Final Abstract Number: 46.007
Session: Emerging Infectious Diseases
Date: Friday, June 15, 2012
Time: 12:45-14:15
Room: Poster & Exhibition Area
Helicobacteriosis: An emerging disease for domestic animals
and humans in Venezuela
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Polanco3, A. Morales1
1 Central University of Venezuela - College of Vterinary Medicine,
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Background: Helicobacteriosis a recognized disease world-
wide. In Venezuela, Helicobacter pyloris formally identiﬁed for
several years diagnosed by serology, saliva urease test, PCR and
cultures. Its role in gastritis and cancer promotion has been
ascertained. It have been studied inmany animalmodels. NewHeli-
cobacter spp. have been identiﬁed with close DNA homogeneity to
H. pyloris. In our country, we have studied the role of the bacterium
in Gastritis in dogs, horses and swine by using PCR, urease test and
ELISA. Helicobacter spp has been identiﬁed in above models related
to gastro-duodenal ulcer syndrome (GDUS) and MALT associated
gastritis.
Methods: Prevalence of Helicobacter spp studied by videoen-
doscopy, biopsies and stomach lavages in dogs (N= 30), horses (N=
20) and swine (N= 100), as necropsies in euthanized horses (N= 30)
andswineat slaughterhouse (N=400).HelicobacterDNAextraction-
was done amplifying speciﬁc primers of fragment of 399bp from
RNAr gen 16S, H. pyloris glimM gen of 294 pb and 128 pb of cagA
gen. Biopsies and gastroduodenal tissuewere stainned to identiﬁed
spiral bacteria free, attached or intracytoplasmatically in epithelial
cells, urease test and Elisa. Interaction of Porcine Circovirus with
presence of Helycobacter-Like bacteria was studied by qPCR and
cElisa in GDUS.
Results: Overall prevalence of Helicobacter was 20% in dogs,
27% in horses and 67% in swine. Urease test was highly (+) 85%
in dogs, horses 35% and swine 85%. Stomach content in horses pH
8 o greater, as in swine with GDUS, compared to normal stomachs
pH 3 - 5. Prevalence of Helicobacter-like spiral bacteria were seen in
normal stomachs (30%) and stomachs with GDUS (80%). Helicobac-
ter sp. extracted DNA identiﬁed in all models studied. Homogeneity
to H. pyloris 95% in dogs and horses.High seroconversion to PCV2
(75%, p GDUS up to 10◦ Log of PCV2 DNA, compared to normal
swine. Acknowledge funding to CDCH-UCV # PG 11.00.6631.2007.
Conclusion: Helicobacter spp. presence in tissue correlated
(pGDUS. Clinical evaluation of patients, videoendoscopy versus
histopathology are key steps to diagnose Helicobacteriosis disease.
H. equorum and H. suis develop lesions similar to humans. Thehttp://dx.doi.org/10.1016/j.ijid.2012.05.879
